Researchers have employed a cross-species immunological analysis to provide new insights into a smallpox vaccine's ...

Monkeypox is a disease caused by the monkeypox virus, a pathogen closely related to variola virus, which causes smallpox.

Monkeypox, caused by the monkeypox virus—a close cousin of smallpox—has spread rapidly worldwide. From 2022 to 2025, more than 133,000 cases were reported across 131 countries. In August 2024, the ...

The recent global monkeypox (mpox) outbreak, with a new and aggressive variant, has underscored the dire need for safe, broadly effective, and accessible vaccines. The LC16m8 vaccine, an attenuated ...

Another shot called ACAM2000 from Emergent BioSolutions is licensed for smallpox but could also provide protection against monkeypox if authorised. Meanwhile, SIGA Technologies' oral drug Tpoxx ...

LC16m8 is an attenuated vaccinia virus strain that was originally developed in Japan for smallpox and was later approved for monkeypox in 2022. LC16m8 has demonstrated efficacy and immunogenicity ...

With new and aggressive strains of the mpox virus wreaking havoc across the world, the need for safe and effective vaccines ...

TPOXX is approved in Europe for the treatment of monkeypox and in the US and elsewhere for the treatment of smallpox, but can be prescribed off-label. One of the new countries stockpiling the drug ...

The NCDHHS has warned N.C. residents about detections of mpox particles associated with more serious symptoms.

LC16m8 is an attenuated vaccinia virus strain that was originally developed in Japan for smallpox and was later approved for monkeypox in 2022. LC16m8 has demonstrated efficacy and immunogenicity ...